Traneurocin

N/A

Report date: 2024/04/30 15:18:14
NME

Base Information

Drug NameTraneurocin
Drug Alias NameN-831NA-831
ClassificationSmall molecules
Mechanisms of ActionGlutamate receptor ionotropic AMPA agonists
TargetsGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Neuroinflammatory DiseasesCognitive Dysfunction +[14] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew Zealand
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeuroactiva Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiomed Industries Inc
Inactive CompaniesNeuroactiva Inc
Active IndicationsAlzheimer Disease
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Neuroinflammatory DiseasesCognitive Dysfunction +[13] 

Other Information

ATC CodeN/A
Related LinksN/A